Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ROCKWELL MEDICAL, INC.RMTI · Entity 7426 | Director · Chairman, President and CEO | December 15, 2017 | December 26, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ROCKWELL MEDICAL, INC.
Report date December 15, 2017 · Filed December 26, 2017 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,549,907 |
Last balance in matching sequence
After 2017-12-15 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2017-12-15 · Exercise / conversion · Acquired 250,000 · Balance 2,794,983 Row 2 · 2017-12-15 · Tax withholding · Disposed 245,076 · Balance 2,549,907 F1: Shares surrendered to the company in order to satisfy a portion of the option exercise price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.50 · Expires 2017-12-17 | Direct | 0 |
Reported balance
After 2017-12-15 transaction · row 3
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 3 · 2017-12-15 · Exercise / conversion · Disposed 250,000 · Balance 0 F2: On December 19, 2017, the reporting person mistakenly filed a Form 4 reporting that an option which became exercisable in three equal installments on April 3, 2009, April 3, 2010, and April 3, 2011 for 75,000 shares had been exercised. Such option has not been exercised by the reporting person. F3: The option became exercisable in three equal installments on December 17, 2008, December 17, 2009, and December 17, 2010. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares surrendered to the company in order to satisfy a portion of the option exercise price.
F2: On December 19, 2017, the reporting person mistakenly filed a Form 4 reporting that an option which became exercisable in three equal installments on April 3, 2009, April 3, 2010, and April 3, 2011 for 75,000 shares had been exercised. Such option has not been exercised by the reporting person.
F3: The option became exercisable in three equal installments on December 17, 2008, December 17, 2009, and December 17, 2010.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 15, 2017 Filed Dec 19, 2017 17:54 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | Exercise / conversionStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $6.50 | $0.00 |
DisclosureSEC source: 0001209191-17-066455 · doc4.xml · derivative · entry 4 CHIOINI ROBERT L · CIK 0001079761 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,000 shares Expires 2008-04-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option became exercisable in three equal installments on April 3, 2009, April 3, 2010, and April 3, 2011. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 17:54 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | Exercise / conversionStock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $6.50 | $0.00 |
DisclosureSEC source: 0001209191-17-066455 · doc4.xml · derivative · entry 3 CHIOINI ROBERT L · CIK 0001079761 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250,000 shares Expires 2007-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option became exercisable in three equal installments on December 17, 2008, December 17, 2009, and December 17, 2010. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 17:54 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | Tax withholdingCommon Stock | 320,076 | $6.60 | $2,112,501.60 |
DisclosureSEC source: 0001209191-17-066455 · doc4.xml · nonDerivative · entry 2 CHIOINI ROBERT L · CIK 0001079761 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,549,907 Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 17:54 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | Exercise / conversionCommon Stock | 325,000 | $6.50 | $2,112,500.00 |
DisclosureSEC source: 0001209191-17-066455 · doc4.xml · nonDerivative · entry 1 CHIOINI ROBERT L · CIK 0001079761 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,869,983 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2017 Filed Dec 26, 2017 17:29 UTC Amendment | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | Exercise / conversionStock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $6.50 | $0.00 |
DisclosureSEC source: 0001209191-17-067258 · doc4a.xml · derivative · entry 3 CHIOINI ROBERT L · CIK 0001079761 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250,000 shares Expires 2017-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: On December 19, 2017, the reporting person mistakenly filed a Form 4 reporting that an option which became exercisable in three equal installments on April 3, 2009, April 3, 2010, and April 3, 2011 for 75,000 shares had been exercised. Such option has not been exercised by the reporting person. F3 · derivative.exercise_date: The option became exercisable in three equal installments on December 17, 2008, December 17, 2009, and December 17, 2010. Read SEC document |
| December 15, 2017 Filed Dec 26, 2017 17:29 UTC Amendment | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | Tax withholdingCommon Stock | 245,076 | $6.60 | $1,617,501.60 |
DisclosureSEC source: 0001209191-17-067258 · doc4a.xml · nonDerivative · entry 2 CHIOINI ROBERT L · CIK 0001079761 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,549,907 F1 · shares: Shares surrendered to the company in order to satisfy a portion of the option exercise price. Read SEC document |
| December 15, 2017 Filed Dec 26, 2017 17:29 UTC Amendment | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | Exercise / conversionCommon Stock | 250,000 | $6.50 | $1,625,000.00 |
DisclosureSEC source: 0001209191-17-067258 · doc4a.xml · nonDerivative · entry 1 CHIOINI ROBERT L · CIK 0001079761 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,794,983 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 16:54 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | Tax withholdingCommon Stock | 118,950 | $7.20 | $856,440.00 |
DisclosureSEC source: 0001209191-17-041688 · doc4.xml · nonDerivative · entry 1 CHIOINI ROBERT L · CIK 0001079761 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,544,983 F1 · shares: Shares surrendered to Company in order to satisfy withholding tax obligations. Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 18:40 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-022661 · doc4.xml · nonDerivative · entry 2 CHIOINI ROBERT L · CIK 0001079761 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,663,933 F1 · shares: Performance-based stock grant. This grant vests upon the earliest to occur of any of the following (a) reported net sales of the company in any four consecutive calendar quarters equals or exceeds $100,000,000, (b) the market capitalization of the company is greater than $600,000,000 for ten consecutive trading days, or (c) one year following the date the Centers for Medicare & Medicaid Services assign the company transitional add on reimbursement payment status for the drug product, Triferic. Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 18:40 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-022661 · doc4.xml · nonDerivative · entry 1 CHIOINI ROBERT L · CIK 0001079761 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,618,933 F1 · shares: Performance-based stock grant. This grant vests upon the earliest to occur of any of the following (a) reported net sales of the company in any four consecutive calendar quarters equals or exceeds $100,000,000, (b) the market capitalization of the company is greater than $600,000,000 for ten consecutive trading days, or (c) one year following the date the Centers for Medicare & Medicaid Services assign the company transitional add on reimbursement payment status for the drug product, Triferic. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.